XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 15, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2022
Allocated share-based compensation expense (reversal)   $ 92.3 $ 83.8 $ 260.8 $ 255.1  
Cost of revenue            
Allocated share-based compensation expense (reversal)   5.8 5.8 17.0 17.6  
Research and development            
Allocated share-based compensation expense (reversal) [1]   66.7 58.6 186.3 178.9  
Research and development | President            
Allocated share-based compensation expense (reversal) $ (6.7)         $ 4.4
Sales and marketing            
Allocated share-based compensation expense (reversal)   6.1 5.2 17.4 17.0  
General and administrative            
Allocated share-based compensation expense (reversal)   $ 13.7 $ 14.2 $ 40.1 $ 41.6  
[1] On March 15, 2023, the Company's former President resigned, resulting in the reversal of $6.7 million in stock-based compensation expense. Of the total amount reversed, $4.4 million related to expense recognized prior to January 1, 2023.